Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Keon Uk Park"'
Autor:
Sung Hoon Sim, Jeong Eun Kim, Min Hwan Kim, Yeon Hee Park, Jee Hyun Kim, Koung Jin Suh, Su-Jin Koh, Kyong Hwa Park, Myoung Joo Kang, Mi Sun Ahn, Kyoung Eun Lee, Hee-Jun Kim, Hee Kyung Ahn, Han Jo Kim, Keon Uk Park, Jae Ho Byun, Jin Hyun Park, Gyeong-Won Lee, Keun Seok Lee, Joohyuk Sohn, Kyung Hae Jung, In Hae Park
Publikováno v:
The Breast. 65:172-178
We investigated the efficacy and safety of a trastuzumab biosimilar, Herzuma®, in combination with treatment of physician's choice (TPC) in patients with HER2+ metastatic breast cancer (MBC) who had failed at least two HER2 directed chemotherapies.
Autor:
Bhumsuk Keam, Keon Uk Park, Hye Ryun Kim, Keun-Wook Lee, Sung-Bae Kim, Seong Hoon Shin, Jin-Hyuk Choi, Eun Joo Kang, Yun-Gyoo Lee, Hyo Jung Kim, Min Kyoung Kim, Hwan Jung Yun, Kyoung Eun Lee, Jin-Soo Kim, Hee Kyung Ahn
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
Purpose Certain patient subgroups who do not respond to induction chemotherapy (IC) show inherent chemoresistance in locally advanced head and neck squamous cell carcinoma (LA-HNSCC). This study aimed to assess the prognostic value of IC, and role of
Autor:
Hye Ryun Kim, Hyun Chang, Keun-Wook Lee, Myung-Ju Ahn, Seong Hoon Shin, Ho Jung An, Sung-Bae Kim, Sang Hoon Chun, Yun-Gyoo Lee, Ji Hyun Park, Kyoung Eun Lee, In Gyu Hwang, Keon Uk Park, Bhumsuk Keam
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
Purpose This study was conducted to determine the effectiveness of immune checkpoint inhibitors (ICIs) in recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) after platinum-containing chemotherapy. We also identified clinical bi
Autor:
Byoung Chul Cho, Seong Gu Heo, Young Joo Min, Keon Uk Park, Hyo Song Kim, Tae Min Kim, Min Kyoung Kim, Kyu Ryung Kim, Ik Joo Chung, Yun Gyoo Lee, Hye Ryun Kim, Min Hee Hong, Yoon Ho Ko, Hoon Gu Kim, Jinseon Yoo
Publikováno v:
Cancer. 126:4521-4531
Background The objective of the current study was to investigate the clinical activity of, safety of, and predictive biomarkers for afatinib, an irreversible pan-ErbB kinase inhibitor, in patients with recurrent and/or metastatic esophageal squamous
Autor:
Hee Kyung Ahn, Eun Joo Kang, Seong Hoon Shin, Sung-Bae Kim, Y. Lee, Keon Uk Park, Jung Hye Kwon, Kyoung Eun Lee, Keun Wook Lee, Hwan Jung Yun, Hye Ryun Kim, Min Kyoung Kim, Jin-Soo Kim, Jin-Hyuk Choi, Bhumsuk Keam
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-9 (2020)
BMC Cancer
BMC Cancer
Background By investigating treatment patterns and outcomes in locally advanced head and neck squamous cell carcinoma (LA-HNSCC), we aimed at providing valuable insights into the optimal therapeutic strategy for physicians in real-world practice. Met
Autor:
Keon Uk Park, Jong Gwang Kim, Sang Cheul Oh, Jae Yong Cho, Sun Kyung Baek, Ik Joo Chung, Myung Ah Lee, Jaewon Lee, Joong Bae Ahn, Yeul Hong Kim, Jin Won Kim, Doyeun Oh, Byoung-Yong Shim, Kyung Hee Lee, Dongbok Shin, Sae-Won Han
Publikováno v:
European Journal of Cancer. 130:51-62
Background Cancer-related fatigue (CRF) is a common symptom and has a negative impact on prognosis in cancer patients. CRF could be improved by Korean red ginseng (KRG). Patients and methods For this randomised and double-blinded trial, colorectal ca
Autor:
Jang Ho Cho, Eun Joo Kang, Se-Hoon Lee, Jin Seok Ahn, Keon Uk Park, Myung-Ju Ahn, Sung Hee Lim, Ki Hwan Kim, Yoonhee Choi, Keunchil Park, Myung Hee Lee, Jong Mu Sun, Ho Jung An, Mi Sun Ahn
Publikováno v:
Journal of Clinical Oncology. 38:488-495
PURPOSE Approximately 10% of patients with epidermal growth factor receptor (EGFR) mutation–positive non–small-cell lung cancer (NSCLC) harbor uncommon mutations. Here, we report the efficacy and safety of osimertinib in patients with NSCLC harbo
Autor:
Moon Young Choi, Eun Kyung Cho, Hoon Gu Kim, Jinhyun Cho, Hye Ryun Kim, Ha Yeon Lee, Heui June Ahn, Keunchil Park, Ki Hyeong Lee, Myung-Ju Ahn, Hwan Jung Yun, Jin Hyoung Kang, Se-Hoon Lee, Su Jin Lee, K.H. Yoo, Yoonhee Choi, Sin-Ho Jung, Jong Mu Sun, Keon Uk Park, Jin Seok Ahn, Jaeheon Jeong, Kihwan Kim
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
Purpose The optimal cytotoxic regimens have not been established for patients with non-small cell lung cancer (NSCLC) who develop disease progression on first-line epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI). Materials and m
Autor:
Eun Joo Kang, Sun Min Lim, Yoon Ho Ko, Joo Hang Kim, Sangwoo Kim, Byoung Chul Cho, Hee Kyung Ahn, Hyun Chang, Dongmin Jung, Byung-Ho Nam, Keun-Wook Lee, Hye Ryun Kim, Jung Hye Kwon, Ji Eun Kim, Sang-Hee Cho, In Gyu Hwang, Myung-Ju Ahn, Keon Uk Park, Ji Hyung Hong, Sang Hoon Chun, Hwan Jung Yun, Jae Woo Choi, Tak Yun, Min Kyoung Kim, Jong Gwon Choi, Hyun Woo Lee, Ji Won Kim, Bhumsuk Keam, Jin-Soo Kim
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
Purpose Head and neck squamous cell carcinoma (HNSCC) is a deadly disease in which precision medicine needs to be incorporated. We aimed to implement next-generation sequencing (NGS) in determining actionable targets to guide appropriate molecular ta
Autor:
Kyung Hae Jung, Ho Suk Oh, Keon Uk Park, Kyong Hwa Park, Jin-Hee Ahn, Yoon Ji Choi, Jae Hong Seo, Jinho Yoo, Ho Young Kim, In Sil Choi, Suee Lee, Soohyeon Lee, Seok Yun Kang, Ju Won Kim, Hye Sook Kim, Kyung Hun Lee, Kyung Eun Lee, In Hae Park, Hee Jun Kim, Yeon Hee Park
Publikováno v:
Cytokine. 142
Advanced breast cancer frequently metastasizes to the skeleton causing major mobility issues and hazards to quality of life. To manage osteolytic bone metastasis, bone-modifying agents and chemotherapy are recommended as the standard of care. Here, w